Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib in Pneumonic-type Lung Adenocarcinoma
NCT00198380Phase 2Completed
- Sponsor
- IFCT
- Start
- Apr 2005
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in lung adenocarcinoma, sponsored by IFCT. Started Apr 2005; status: completed.
02
Drugs
03
Conditions
lung adenocarcinoma
Beyond the preview
Go deeper on NCT00198380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00198380.